1. No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model
   M. Elizabeth Moss et al, 2018, Frontiers in Cardiovascular Medicine CrossRef
2. Zinc oxide nanoparticles and spironolactone-enhanced Nrf2/HO-1 pathway and inhibited Wnt/β-catenin pathway in adenine-induced nephrotoxicity in rats
   Amira Awadalla et al, 2022, Redox Report CrossRef
3. CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy
   Jing Zhao et al, 2019, Mediators of Inflammation CrossRef
4. Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
   Dong-Lim Kim et al, 2023, Endocrinology and Metabolism CrossRef
5. Erzhi Formula Extracts Reverse Renal Injury in Diabetic Nephropathy Rats by Protecting the Renal Podocytes
   Jun Jiang et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Clinicopathological Characteristics and Risk Factors for Rapid eGFR Decline in Chinese Patients with Biopsy-Proven Obesity-Related Glomerulopathy
   Jia Yang et al, 2023, Diabetes, Metabolic Syndrome and Obesity CrossRef
7. Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
   Xing Chen et al, 2022, Drug Design, Development and Therapy CrossRef
8. Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention
   Shuting Yang et al, 2020, Kidney and Blood Pressure Research CrossRef